FAQFAQ   SearchSearch   MemberlistMemberlist   UsergroupsUsergroups   RegisterRegister 
 ProfileProfile   PreferencesPreferences   Log in to check your private messagesLog in to check your private messages   Log inLog in 
Forum index » diseases » cancer
Treatment of acute myeloid leukemia / Valproic acid
Post new topic   Reply to topic Page 1 of 1 [2 Posts] View previous topic :: View next topic
Author Message
ironjustice@aol.com
medicine forum Guru


Joined: 28 Apr 2005
Posts: 1522

PostPosted: Mon Jun 13, 2005 6:36 am    Post subject: Treatment of acute myeloid leukemia / Valproic acid Reply with quote

Cancer Res. 2005 Apr 1;65(7):2537-41. Related Articles, Links


Valproic acid stimulates proliferation and self-renewal of
hematopoietic stem cells.

Bug G, Gul H, Schwarz K, Pfeifer H, Kampfmann M, Zheng X, Beissert T,
Boehrer S, Hoelzer D, Ottmann OG, Ruthardt M.

Medizinische Klinik II/Abteilung Hamatologie, Klinikum der Johann
Wolfgang Goethe-Universitat, Frankfurt, Germany.

Histone deacetylase inhibitors have attracted considerable attention
because of their ability to overcome the differentiation block in
leukemic blasts, an effect achieved either alone or in combination with
differentiating agents, such as all-trans retinoic acid. We have
previously reported favorable effects of the potent histone deacetylase
inhibitor valproic acid in combination with all-trans retinoic acid in
patients with advanced acute myeloid leukemia leading to blast cell
reduction and improvement of hemoglobin. These effects were accompanied
by hypergranulocytosis most likely due to an enhancement of nonleukemic
myelopoiesis and the suppression of malignant hematopoiesis rather than
enforced differentiation of the leukemic cells. These data prompted us
to investigate the effect of valproic acid on normal hematopoietic stem
cells (HSC). Here we show that valproic acid increases both
proliferation and self-renewal of HSC. It accelerates cell cycle
progression of HSC accompanied by a down-regulation of
p21(cip-1/waf-1). Furthermore, valproic acid inhibits GSK3beta by
phosphorylation on Ser9 accompanied by an activation of the Wnt
signaling pathway as well as by an up-regulation of HoxB4, a target
gene of Wnt signaling. Both are known to directly stimulate the
proliferation of HSC and to expand the HSC pool. In summary, we here
show that valproic acid, known to induce differentiation or apoptosis
in leukemic blasts, stimulates the proliferation of normal HSC, an
effect with a potential effect on its future role in the treatment of
acute myeloid leukemia.

PMID: 15805245 [PubMed - indexed for MEDLINE]

--------------------------------------------------------------------------------

Who loves ya.
Tom
Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com
Man Is A Herbivore!
http://pages.ivillage.com/ironjustice/manisaherbivore
DEAD PEOPLE WALKING
http://pages.ivillage.com/ironjustice/deadpeoplewalking
Back to top
J
medicine forum addict


Joined: 07 May 2005
Posts: 93

PostPosted: Mon Jun 13, 2005 6:59 am    Post subject: Re: Treatment of acute myeloid leukemia / Valproic acid Reply with quote

"ironjustice@aol.com" wrote:

Quote:
Cancer Res. 2005 Apr 1;65(7):2537-41.

Valproic acid stimulates proliferation and self-renewal of
hematopoietic stem cells.
[...] with a potential effect on its future role in the treatment of acute myeloid
leukemia.

http://www.clinicaltrials.gov/show/NCT00079378
Record first received: March 8, 2004
Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute
Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small
Lymphocytic Lymphoma
This study is currently recruiting patients.
RATIONALE: Drugs used in chemotherapy, such as decitabine, work in different ways to
stop cancer cells from dividing so they stop growing or die. Valproic acid may stop
the growth of cancer cells by blocking the enzymes necessary for their growth.
Combining decitabine with valproic acid may kill more cancer cells.

PURPOSE: This phase I trial is studying the side effects and best dose of decitabine
and valproic acid in treating patients with refractory or relapsed acute myeloid
leukemia or previously treated chronic lymphocytic leukemia or small lymphocytic
leukemia.

OBJECTIVES: Primary

* Determine the minimally effective pharmacological dose (MEPD) of decitabine in
patients with refractory or relapsed acute myeloid leukemia or with previously
treated chronic lymphocytic lymphoma or small lymphocytic lymphoma.
* Determine the maximum tolerated dose (MTD) of valproic acid in combination
with the MEPD of decitabine in these patients.
* Determine the MEPD of valproic acid in combination with decitabine in these
patients.
* Determine the qualitative and quantitative toxic effects of decitabine alone
and in combination with valproic acid, in terms of organ specificity, time course,
predictability, and reversibility in these patients.


http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a682412.html
MPORTANT WARNING:
Valproic acid can cause serious damage to the liver. Liver damage is more common in
children under two years old; talk to your doctor about your child's risk from
taking valproic acid. Valproic acid can also cause life-threatening inflammation of
the pancreas. If you experience any of the following symptoms, call your doctor
immediately: recurring seizures after they have been controlled by medication,
stomach pain, upset stomach, recurring seizures, loss of appetite, vomiting, dark
urine, weakness, tiredness, lack of energy, facial swelling, and yellowing of the
skin or eyes. Keep all appointments with your doctor and the laboratory. Your doctor
will order certain lab tests to check your response to valproic acid.Before taking
valproic acid, tell your doctor if you are pregnant or planning to become pregnant.
If you become pregnant while taking valproic acid, call your doctor. Valproic acid
can cause birth defects in the fetus. Talk to your doctor about the risk of taking
valproic acid during pregnancy.

Why is this medication prescribed?

Valproic acid is used, alone or with other drugs, to treat certain types of seizures
in the treatment of epilepsy. It is also used to prevent migraine headaches and to
treat various psychiatric illnesses, such as bipolar disorder and aggression.
Back to top
Google

Back to top
Display posts from previous:   
Post new topic   Reply to topic Page 1 of 1 [2 Posts] View previous topic :: View next topic
The time now is Sat Jan 10, 2009 3:42 am | All times are GMT
Forum index » diseases » cancer
Jump to:  

Similar Topics
Topic Author Forum Replies Last Post
No new posts Matrix metalloproteinase-9 / chloroge... ironjustice@aol.com nutrition 1 Tue Jul 18, 2006 10:41 pm
No new posts Vitamin C treatment shows cancer promise BreastImplantAwareness.or cancer 2 Sun Jul 16, 2006 12:21 am
No new posts Vitamin C treatment shows cancer promise \"Jan Drew\" cancer 0 Sat Jul 15, 2006 11:50 pm
No new posts What alternative treatment? Mr-Natural-Health nutrition 0 Thu Jul 13, 2006 1:26 am
No new posts Mahjong "a viable treatment option" f... William Wagner cardiology 8 Thu Jul 06, 2006 10:33 am

Libros | Science News | Debt Consolidation | Bankruptcy | Credit Counseling
Copyright © 2004-2005 DeniX Solutions SRL
Other DeniX Solutions sites: electronics forum, Science forum Unix/Linux blog Unix/Linux documentation Unix/Linux forums


Powered by phpBB © 2001, 2005 phpBB Group
[ Time: 0.1648s ][ Queries: 16 (0.0700s) ][ GZIP on - Debug on ]